OUR PRODUCTS

MOBILE APPS

GENERAL INFO

DMAC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

DiaMedica Therapeutics (DMAC) Earnings Date & Reports

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DMAC is expected to report earnings to fall 5.56% to -17 cents per share on November 05

DiaMedica Therapeutics DMAC Stock Earnings Reports

Q3'25

Est.

$-0.17

Q2'25

Beat

by $0.01

Q1'25

Beat

by $0.02

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.01

The last earnings report on August 12 showed earnings per share of -18 cents, beating the estimate of -18 cents. With 25.54K shares outstanding, the current market capitalization sits at 295.14M.

View a ticker or compare two or three

Compare

DMAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For DMAC
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DMAC showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

301 Carlson Parkway

Phone

+1 763 496-5454

Employees

Web

https://www.diamedica.com